Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spinal Neoplasms | 12 | 2023 | 715 | 2.200 |
Why?
|
Isocitrate Dehydrogenase | 4 | 2024 | 951 | 1.330 |
Why?
|
Central Nervous System Neoplasms | 4 | 2024 | 928 | 1.300 |
Why?
|
Spinal Cord Neoplasms | 5 | 2023 | 263 | 0.970 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2017 | 456 | 0.900 |
Why?
|
Amyloid beta-Peptides | 17 | 2014 | 3914 | 0.850 |
Why?
|
Lymphoma | 3 | 2024 | 1897 | 0.850 |
Why?
|
Telomerase | 5 | 2024 | 751 | 0.800 |
Why?
|
Brain Neoplasms | 8 | 2024 | 9116 | 0.730 |
Why?
|
Meningioma | 3 | 2018 | 1220 | 0.690 |
Why?
|
Meningeal Neoplasms | 3 | 2018 | 1253 | 0.680 |
Why?
|
Mutation | 12 | 2024 | 30211 | 0.660 |
Why?
|
Cyanides | 1 | 2018 | 82 | 0.600 |
Why?
|
Neoplasm Proteins | 3 | 2021 | 3601 | 0.600 |
Why?
|
Neurosurgical Procedures | 7 | 2024 | 2076 | 0.590 |
Why?
|
Guanidines | 1 | 2018 | 194 | 0.580 |
Why?
|
Glioma | 5 | 2023 | 3503 | 0.570 |
Why?
|
Tumor Suppressor Proteins | 2 | 2017 | 2800 | 0.560 |
Why?
|
Spinal Fusion | 6 | 2021 | 1307 | 0.540 |
Why?
|
Rhabdoid Tumor | 1 | 2017 | 211 | 0.480 |
Why?
|
Glioblastoma | 4 | 2024 | 3463 | 0.470 |
Why?
|
Hemangioblastoma | 1 | 2014 | 62 | 0.460 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1374 | 0.450 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 304 | 0.420 |
Why?
|
Synapses | 6 | 2014 | 1765 | 0.420 |
Why?
|
Patient Care | 1 | 2017 | 629 | 0.390 |
Why?
|
Osteosarcoma | 1 | 2017 | 911 | 0.370 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 618 | 0.350 |
Why?
|
Spondylolisthesis | 2 | 2024 | 173 | 0.350 |
Why?
|
Cauda Equina | 1 | 2010 | 45 | 0.350 |
Why?
|
Ganglioneuroma | 1 | 2010 | 53 | 0.340 |
Why?
|
Cerebellar Neoplasms | 1 | 2014 | 591 | 0.330 |
Why?
|
Spine | 6 | 2024 | 1140 | 0.330 |
Why?
|
Molecular Targeted Therapy | 2 | 2018 | 2824 | 0.330 |
Why?
|
Spinal Diseases | 4 | 2024 | 561 | 0.330 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2010 | 133 | 0.320 |
Why?
|
Carcinoma, Renal Cell | 2 | 2022 | 3187 | 0.310 |
Why?
|
Paraganglioma | 1 | 2010 | 143 | 0.310 |
Why?
|
Lumbar Vertebrae | 3 | 2024 | 1885 | 0.290 |
Why?
|
Kidney Neoplasms | 2 | 2022 | 4282 | 0.280 |
Why?
|
Alzheimer Disease | 10 | 2014 | 8761 | 0.260 |
Why?
|
Hippocampus | 7 | 2011 | 3786 | 0.260 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2011 | 903 | 0.250 |
Why?
|
Bone Transplantation | 2 | 2020 | 925 | 0.240 |
Why?
|
Genotype | 1 | 2018 | 13042 | 0.220 |
Why?
|
Surgery, Computer-Assisted | 2 | 2021 | 1002 | 0.210 |
Why?
|
Patient Selection | 1 | 2014 | 4258 | 0.200 |
Why?
|
Immunoprecipitation | 5 | 2011 | 874 | 0.190 |
Why?
|
Long-Term Potentiation | 5 | 2014 | 290 | 0.190 |
Why?
|
Longevity | 1 | 2009 | 1078 | 0.190 |
Why?
|
Antigens, CD19 | 1 | 2024 | 446 | 0.190 |
Why?
|
Humans | 62 | 2024 | 767991 | 0.190 |
Why?
|
Melanoma | 2 | 2017 | 5706 | 0.190 |
Why?
|
Immunotherapy | 1 | 2017 | 4748 | 0.190 |
Why?
|
Promoter Regions, Genetic | 3 | 2024 | 5798 | 0.180 |
Why?
|
Spinal Cord Compression | 1 | 2023 | 234 | 0.180 |
Why?
|
Drug Delivery Systems | 2 | 2024 | 2230 | 0.180 |
Why?
|
Neurotoxicity Syndromes | 1 | 2023 | 302 | 0.170 |
Why?
|
Brain | 7 | 2012 | 27366 | 0.160 |
Why?
|
DNA, Neoplasm | 1 | 2024 | 1742 | 0.160 |
Why?
|
Hemostatic Techniques | 1 | 2020 | 116 | 0.160 |
Why?
|
Ketones | 1 | 2020 | 183 | 0.160 |
Why?
|
Neuronal Plasticity | 5 | 2014 | 1448 | 0.160 |
Why?
|
Zygapophyseal Joint | 1 | 2020 | 129 | 0.150 |
Why?
|
Combined Modality Therapy | 4 | 2018 | 8535 | 0.150 |
Why?
|
Memory | 1 | 2008 | 2208 | 0.150 |
Why?
|
Peptide Fragments | 7 | 2014 | 5151 | 0.150 |
Why?
|
Teriparatide | 1 | 2020 | 226 | 0.150 |
Why?
|
Chondrosarcoma | 1 | 2021 | 305 | 0.150 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1512 | 0.140 |
Why?
|
Tranexamic Acid | 1 | 2020 | 174 | 0.140 |
Why?
|
Dystrophin | 1 | 2018 | 284 | 0.140 |
Why?
|
Blotting, Western | 5 | 2011 | 5024 | 0.140 |
Why?
|
CHO Cells | 6 | 2014 | 1379 | 0.130 |
Why?
|
Antifibrinolytic Agents | 1 | 2020 | 289 | 0.130 |
Why?
|
Mice, SCID | 2 | 2018 | 2627 | 0.130 |
Why?
|
Cricetulus | 5 | 2014 | 812 | 0.130 |
Why?
|
Paraplegia | 1 | 2016 | 161 | 0.130 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 16041 | 0.130 |
Why?
|
Cricetinae | 6 | 2014 | 2423 | 0.130 |
Why?
|
Retrospective Studies | 11 | 2024 | 81746 | 0.120 |
Why?
|
Plaque, Amyloid | 3 | 2009 | 769 | 0.120 |
Why?
|
Prosthesis Implantation | 1 | 2020 | 595 | 0.120 |
Why?
|
Culture Media, Conditioned | 3 | 2014 | 521 | 0.120 |
Why?
|
Adrenocortical Carcinoma | 1 | 2016 | 88 | 0.120 |
Why?
|
Prognosis | 5 | 2024 | 29979 | 0.120 |
Why?
|
Frozen Sections | 1 | 2015 | 153 | 0.120 |
Why?
|
Chromatography, Gel | 3 | 2011 | 636 | 0.120 |
Why?
|
Radiosurgery | 2 | 2022 | 1330 | 0.120 |
Why?
|
Dacarbazine | 1 | 2017 | 552 | 0.120 |
Why?
|
Intraoperative Period | 1 | 2015 | 512 | 0.110 |
Why?
|
Tissue Fixation | 1 | 2015 | 245 | 0.110 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2016 | 161 | 0.110 |
Why?
|
Female | 25 | 2024 | 397113 | 0.110 |
Why?
|
Disease Progression | 5 | 2018 | 13665 | 0.110 |
Why?
|
Male | 26 | 2024 | 364641 | 0.110 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 1196 | 0.110 |
Why?
|
Cervical Vertebrae | 1 | 2020 | 979 | 0.110 |
Why?
|
Robotics | 1 | 2020 | 813 | 0.110 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 322 | 0.110 |
Why?
|
Amyloid | 2 | 2012 | 854 | 0.110 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2017 | 614 | 0.110 |
Why?
|
Middle Aged | 16 | 2024 | 223422 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2018 | 3609 | 0.100 |
Why?
|
Bone Density Conservation Agents | 1 | 2020 | 797 | 0.100 |
Why?
|
Cerebral Aqueduct | 1 | 2012 | 39 | 0.100 |
Why?
|
Adult | 13 | 2024 | 223583 | 0.100 |
Why?
|
Craniopharyngioma | 1 | 2015 | 279 | 0.100 |
Why?
|
Exosomes | 1 | 2017 | 422 | 0.100 |
Why?
|
Scoliosis | 1 | 2020 | 793 | 0.100 |
Why?
|
Complement C3c | 1 | 2012 | 7 | 0.100 |
Why?
|
Cholesterol | 2 | 2011 | 2914 | 0.100 |
Why?
|
Survival Rate | 2 | 2024 | 12828 | 0.100 |
Why?
|
Carcinoma | 1 | 2023 | 2330 | 0.100 |
Why?
|
Aged | 15 | 2024 | 171446 | 0.100 |
Why?
|
Prospective Studies | 3 | 2024 | 54924 | 0.090 |
Why?
|
Macrophage-1 Antigen | 1 | 2012 | 286 | 0.090 |
Why?
|
Thoracic Vertebrae | 1 | 2016 | 613 | 0.090 |
Why?
|
Treatment Outcome | 8 | 2024 | 65364 | 0.090 |
Why?
|
Gene Deletion | 1 | 2018 | 2673 | 0.090 |
Why?
|
Osteoporosis | 1 | 2020 | 1605 | 0.090 |
Why?
|
Disease Models, Animal | 2 | 2009 | 18344 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2017 | 952 | 0.090 |
Why?
|
Polymerase Chain Reaction | 2 | 2020 | 6071 | 0.090 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 2010 | 124 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2017 | 1409 | 0.080 |
Why?
|
Excitatory Postsynaptic Potentials | 2 | 2011 | 369 | 0.080 |
Why?
|
Postoperative Complications | 3 | 2020 | 15831 | 0.080 |
Why?
|
Recovery of Function | 2 | 2016 | 2981 | 0.080 |
Why?
|
Long-Term Synaptic Depression | 1 | 2009 | 59 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2016 | 2058 | 0.080 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2014 | 1117 | 0.080 |
Why?
|
Models, Biological | 2 | 2023 | 9493 | 0.080 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1883 | 0.080 |
Why?
|
Mice, Inbred DBA | 1 | 2009 | 624 | 0.080 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1731 | 0.080 |
Why?
|
Polymers | 3 | 2020 | 1627 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3414 | 0.080 |
Why?
|
Gene Silencing | 1 | 2014 | 1505 | 0.080 |
Why?
|
Glutamic Acid | 2 | 2015 | 1189 | 0.070 |
Why?
|
Animals | 17 | 2024 | 169222 | 0.070 |
Why?
|
Mice | 11 | 2018 | 82024 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2024 | 59598 | 0.070 |
Why?
|
Peptide Mapping | 1 | 2007 | 260 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 3813 | 0.070 |
Why?
|
Survival Analysis | 2 | 2017 | 10098 | 0.070 |
Why?
|
Karnofsky Performance Status | 2 | 2018 | 162 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3626 | 0.070 |
Why?
|
Pituitary Neoplasms | 1 | 2015 | 1322 | 0.070 |
Why?
|
Dimerization | 1 | 2008 | 887 | 0.070 |
Why?
|
Sequence Analysis, Protein | 1 | 2007 | 264 | 0.070 |
Why?
|
Dendritic Spines | 1 | 2008 | 245 | 0.070 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1335 | 0.070 |
Why?
|
Rats | 5 | 2014 | 23751 | 0.070 |
Why?
|
Phagocytosis | 1 | 2012 | 1530 | 0.070 |
Why?
|
Chromosome Pairing | 1 | 2006 | 46 | 0.060 |
Why?
|
Signal Transduction | 3 | 2011 | 23642 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2014 | 19017 | 0.060 |
Why?
|
Models, Chemical | 1 | 2007 | 610 | 0.060 |
Why?
|
Immunohistochemistry | 3 | 2015 | 11068 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2023 | 21206 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2889 | 0.060 |
Why?
|
Hypercholesterolemia | 1 | 2011 | 1145 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2009 | 1715 | 0.060 |
Why?
|
Neprilysin | 1 | 2007 | 487 | 0.060 |
Why?
|
Anticholesteremic Agents | 1 | 2011 | 972 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4785 | 0.050 |
Why?
|
Internship and Residency | 1 | 2023 | 5952 | 0.050 |
Why?
|
Viscosity | 1 | 2023 | 334 | 0.050 |
Why?
|
Microglia | 1 | 2012 | 1376 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39345 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13489 | 0.050 |
Why?
|
Elasticity | 1 | 2023 | 656 | 0.050 |
Why?
|
Neurons | 3 | 2011 | 9518 | 0.050 |
Why?
|
Quadriplegia | 1 | 2023 | 227 | 0.050 |
Why?
|
Cerebral Hemorrhage | 1 | 2012 | 2655 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 5 | 2018 | 36742 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15442 | 0.050 |
Why?
|
Immunization | 1 | 2005 | 1218 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2016 | 9412 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2007 | 2202 | 0.040 |
Why?
|
Ossification of Posterior Longitudinal Ligament | 1 | 2020 | 17 | 0.040 |
Why?
|
Young Adult | 2 | 2024 | 60048 | 0.040 |
Why?
|
Benzophenones | 1 | 2020 | 57 | 0.040 |
Why?
|
Pseudarthrosis | 1 | 2020 | 54 | 0.040 |
Why?
|
Ultrasonics | 1 | 2021 | 208 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2009 | 9556 | 0.040 |
Why?
|
Ilium | 1 | 2020 | 155 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14163 | 0.040 |
Why?
|
Cohort Studies | 5 | 2024 | 41749 | 0.040 |
Why?
|
Sex Chromatin | 1 | 2018 | 19 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2020 | 686 | 0.040 |
Why?
|
Learning | 1 | 2008 | 1759 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 2 | 2007 | 8120 | 0.040 |
Why?
|
Age Factors | 2 | 2020 | 18407 | 0.040 |
Why?
|
Cell Line, Tumor | 3 | 2020 | 17128 | 0.040 |
Why?
|
Administration, Topical | 1 | 2020 | 703 | 0.040 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 2011 | 451 | 0.040 |
Why?
|
Patch-Clamp Techniques | 2 | 2011 | 928 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6517 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 13091 | 0.040 |
Why?
|
Bone Screws | 1 | 2021 | 534 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 859 | 0.040 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2665 | 0.040 |
Why?
|
Spinal Cord Diseases | 1 | 2020 | 291 | 0.040 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 1 | 2017 | 85 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2020 | 863 | 0.030 |
Why?
|
Serum Albumin | 1 | 2020 | 677 | 0.030 |
Why?
|
Cell Line | 1 | 2011 | 15597 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3251 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 687 | 0.030 |
Why?
|
Spinal Injuries | 1 | 2020 | 300 | 0.030 |
Why?
|
Central Nervous System | 1 | 2023 | 1346 | 0.030 |
Why?
|
Time Factors | 2 | 2015 | 40214 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2023 | 2731 | 0.030 |
Why?
|
Piperidines | 2 | 2017 | 1667 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2020 | 642 | 0.030 |
Why?
|
Low Back Pain | 1 | 2024 | 990 | 0.030 |
Why?
|
Acrylamides | 1 | 2017 | 261 | 0.030 |
Why?
|
Osteoporotic Fractures | 1 | 2020 | 417 | 0.030 |
Why?
|
Decompression, Surgical | 1 | 2020 | 603 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2120 | 0.030 |
Why?
|
Spinal Cord | 1 | 2023 | 1811 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2018 | 563 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11873 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2012 | 22381 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 10396 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7445 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 303 | 0.030 |
Why?
|
Parkinson Disease | 1 | 2008 | 2893 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2018 | 13499 | 0.030 |
Why?
|
Valine | 1 | 2015 | 410 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2010 | 5813 | 0.030 |
Why?
|
Spinal Fractures | 1 | 2020 | 710 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22365 | 0.030 |
Why?
|
Enzyme Inhibitors | 2 | 2017 | 3726 | 0.030 |
Why?
|
NAD | 1 | 2017 | 618 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 386 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2012 | 6228 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2396 | 0.030 |
Why?
|
Electrophysiology | 2 | 2006 | 1266 | 0.030 |
Why?
|
Scavenger Receptors, Class A | 1 | 2012 | 52 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4114 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3858 | 0.020 |
Why?
|
Microinjections | 1 | 2012 | 319 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2016 | 1788 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2023 | 2420 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 736 | 0.020 |
Why?
|
PubMed | 1 | 2011 | 129 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2341 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2012 | 866 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2004 | 3977 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1760 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3948 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 1014 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14718 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2024 | 7851 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 819 | 0.020 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2014 | 616 | 0.020 |
Why?
|
Ryanodine | 1 | 2009 | 46 | 0.020 |
Why?
|
Drug Stability | 1 | 2010 | 291 | 0.020 |
Why?
|
Imidazoles | 1 | 2015 | 1168 | 0.020 |
Why?
|
Bicuculline | 1 | 2009 | 96 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5314 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2018 | 2428 | 0.020 |
Why?
|
GABA Antagonists | 1 | 2009 | 119 | 0.020 |
Why?
|
Walking | 1 | 2016 | 1201 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 9252 | 0.020 |
Why?
|
Biophysics | 1 | 2009 | 379 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2016 | 3553 | 0.020 |
Why?
|
Extracellular Fluid | 1 | 2009 | 165 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3532 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 694 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4857 | 0.020 |
Why?
|
Reoperation | 1 | 2018 | 4329 | 0.020 |
Why?
|
Bone Density | 1 | 2020 | 3573 | 0.020 |
Why?
|
Solubility | 1 | 2009 | 1083 | 0.020 |
Why?
|
Calcium | 2 | 2011 | 5794 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2009 | 1065 | 0.020 |
Why?
|
Lysosomes | 1 | 2012 | 938 | 0.020 |
Why?
|
Half-Life | 1 | 2007 | 651 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 4525 | 0.020 |
Why?
|
Decision Making | 1 | 2020 | 3952 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10627 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10264 | 0.020 |
Why?
|
Protein Denaturation | 1 | 2006 | 242 | 0.020 |
Why?
|
United States | 2 | 2024 | 73027 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13289 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2953 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1972 | 0.020 |
Why?
|
Diamines | 1 | 2005 | 60 | 0.020 |
Why?
|
Ligands | 1 | 2012 | 3284 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2010 | 965 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 2011 | 1034 | 0.010 |
Why?
|
Injections, Intraventricular | 1 | 2004 | 227 | 0.010 |
Why?
|
Drug Interactions | 1 | 2009 | 1419 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5366 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12075 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 1168 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2009 | 1740 | 0.010 |
Why?
|
Transfection | 1 | 2012 | 5757 | 0.010 |
Why?
|
Biopsy | 1 | 2016 | 6786 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2018 | 12797 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12536 | 0.010 |
Why?
|
Conditioning, Operant | 1 | 2004 | 307 | 0.010 |
Why?
|
Pyridazines | 1 | 2005 | 203 | 0.010 |
Why?
|
Neutralization Tests | 1 | 2005 | 739 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3428 | 0.010 |
Why?
|
Behavior | 1 | 2005 | 541 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26375 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2403 | 0.010 |
Why?
|
Down-Regulation | 1 | 2009 | 2936 | 0.010 |
Why?
|
alpha-Synuclein | 1 | 2008 | 773 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4426 | 0.010 |
Why?
|
Risk Assessment | 1 | 2022 | 24314 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10757 | 0.010 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2007 | 887 | 0.010 |
Why?
|
Hot Temperature | 1 | 2006 | 1441 | 0.010 |
Why?
|
Risk Factors | 2 | 2020 | 74936 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6668 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5694 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2708 | 0.010 |
Why?
|
Cytokines | 1 | 2012 | 7450 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2012 | 14486 | 0.010 |
Why?
|
Dementia | 1 | 2010 | 2740 | 0.010 |
Why?
|
Computer Simulation | 1 | 2007 | 6283 | 0.010 |
Why?
|
Models, Statistical | 1 | 2007 | 5107 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 89155 | 0.010 |
Why?
|
Incidence | 1 | 2008 | 21532 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2007 | 20218 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20757 | 0.010 |
Why?
|
Child | 1 | 2016 | 80906 | 0.000 |
Why?
|